In  ||| S:0 E:3 ||| IN
Vivo  ||| S:3 E:8 ||| NNP
Visualization  ||| S:8 E:22 ||| NNP
of  ||| S:22 E:25 ||| IN
( ||| S:25 E:26 ||| -LRB-
Auto ||| S:26 E:30 ||| NNP
) ||| S:30 E:31 ||| -RRB-
Immune  ||| S:31 E:38 ||| NNP
Processes  ||| S:38 E:48 ||| NNP
in  ||| S:48 E:51 ||| IN
the  ||| S:51 E:55 ||| DT
Central  ||| S:55 E:63 ||| NNP
Nervous  ||| S:63 E:71 ||| NNP
System  ||| S:71 E:78 ||| NNP
of  ||| S:78 E:81 ||| IN
Rodents  ||| S:81 E:89 ||| NNP
The  ||| S:89 E:93 ||| NNP
CNS  ||| S:93 E:97 ||| NNP
is  ||| S:97 E:100 ||| VBZ
effectively  ||| S:100 E:112 ||| RB
shielded  ||| S:112 E:121 ||| VBN
from  ||| S:121 E:126 ||| IN
the  ||| S:126 E:130 ||| DT
periphery  ||| S:130 E:140 ||| NN
by  ||| S:140 E:143 ||| IN
the  ||| S:143 E:147 ||| DT
blood-brain  ||| S:147 E:159 ||| JJ
barrier  ||| S:159 E:167 ||| NN
( ||| S:167 E:168 ||| -LRB-
BBB ||| S:168 E:171 ||| NNP
)  ||| S:171 E:173 ||| -RRB-
which  ||| S:173 E:179 ||| WDT
limits  ||| S:179 E:186 ||| VBZ
the  ||| S:186 E:190 ||| DT
entry  ||| S:190 E:196 ||| NN
of  ||| S:196 E:199 ||| IN
cells  ||| S:199 E:205 ||| NNS
and  ||| S:205 E:209 ||| CC
solutes ||| S:209 E:216 ||| NN
.  ||| S:216 E:218 ||| .
However ||| S:218 E:225 ||| RB
,  ||| S:225 E:227 ||| ,
in  ||| S:227 E:230 ||| IN
autoimmune  ||| S:230 E:241 ||| JJ
disorders  ||| S:241 E:251 ||| NNS
such  ||| S:251 E:256 ||| JJ
as  ||| S:256 E:259 ||| IN
multiple  ||| S:259 E:268 ||| JJ
sclerosis ||| S:268 E:277 ||| NN
,  ||| S:277 E:279 ||| ,
immune  ||| S:279 E:286 ||| JJ
cells  ||| S:286 E:292 ||| NNS
can  ||| S:292 E:296 ||| MD
overcome  ||| S:296 E:305 ||| VB
this  ||| S:305 E:310 ||| DT
barrier  ||| S:310 E:318 ||| NN
and  ||| S:318 E:322 ||| CC
induce  ||| S:322 E:329 ||| VB
the  ||| S:329 E:333 ||| DT
formation  ||| S:333 E:343 ||| NN
of  ||| S:343 E:346 ||| IN
CNS  ||| S:346 E:350 ||| NNP
inflammatory  ||| S:350 E:363 ||| JJ
lesions ||| S:363 E:370 ||| NNS
.  ||| S:370 E:372 ||| .
Recently ||| S:372 E:380 ||| RB
,  ||| S:380 E:382 ||| ,
two-photon  ||| S:382 E:393 ||| FW
laser  ||| S:393 E:399 ||| FW
scanning  ||| S:399 E:408 ||| FW
microscopy  ||| S:408 E:419 ||| FW
( ||| S:419 E:420 ||| -LRB-
TPLSM ||| S:420 E:425 ||| NNP
)  ||| S:425 E:427 ||| -RRB-
has  ||| S:427 E:431 ||| VBZ
made  ||| S:431 E:436 ||| VBN
it  ||| S:436 E:439 ||| PRP
possible  ||| S:439 E:448 ||| JJ
to  ||| S:448 E:451 ||| TO
visualize  ||| S:451 E:461 ||| VB
autoimmune  ||| S:461 E:472 ||| JJ
processes  ||| S:472 E:482 ||| NNS
in  ||| S:482 E:485 ||| IN
the  ||| S:485 E:489 ||| DT
living  ||| S:489 E:496 ||| NN
CNS  ||| S:496 E:500 ||| NN
in  ||| S:500 E:503 ||| IN
real  ||| S:503 E:508 ||| JJ
time ||| S:508 E:512 ||| NN
.  ||| S:512 E:514 ||| .
However ||| S:514 E:521 ||| RB
,  ||| S:521 E:523 ||| ,
along  ||| S:523 E:529 ||| RB
with  ||| S:529 E:534 ||| IN
a  ||| S:534 E:536 ||| DT
high  ||| S:536 E:541 ||| JJ
microscopy  ||| S:541 E:552 ||| JJ
standard ||| S:552 E:560 ||| NN
,  ||| S:560 E:562 ||| ,
this  ||| S:562 E:567 ||| DT
technique  ||| S:567 E:577 ||| NN
requires  ||| S:577 E:586 ||| VBZ
an  ||| S:586 E:589 ||| DT
advanced  ||| S:589 E:598 ||| JJ
surgical  ||| S:598 E:607 ||| JJ
procedure  ||| S:607 E:617 ||| NN
to  ||| S:617 E:620 ||| TO
access  ||| S:620 E:627 ||| VB
the  ||| S:627 E:631 ||| DT
region  ||| S:631 E:638 ||| NN
of  ||| S:638 E:641 ||| IN
interest ||| S:641 E:649 ||| NN
.  ||| S:649 E:651 ||| .
Here ||| S:651 E:655 ||| RB
,  ||| S:655 E:657 ||| ,
we  ||| S:657 E:660 ||| PRP
describe  ||| S:660 E:669 ||| VBP
in  ||| S:669 E:672 ||| IN
detail  ||| S:672 E:679 ||| NN
the  ||| S:679 E:683 ||| DT
necessary  ||| S:683 E:693 ||| JJ
methodological  ||| S:693 E:708 ||| JJ
steps  ||| S:708 E:714 ||| NNS
to  ||| S:714 E:717 ||| TO
visualize  ||| S:717 E:727 ||| VB
( ||| S:727 E:728 ||| -LRB-
auto ||| S:728 E:732 ||| NN
) ||| S:732 E:733 ||| -RRB-
immune  ||| S:733 E:740 ||| JJ
processes  ||| S:740 E:750 ||| NNS
in  ||| S:750 E:753 ||| IN
living  ||| S:753 E:760 ||| VBG
rodent  ||| S:760 E:767 ||| JJ
tissue ||| S:767 E:773 ||| NN
.  ||| S:773 E:775 ||| .
We  ||| S:775 E:778 ||| PRP
focus  ||| S:778 E:784 ||| VBP
on  ||| S:784 E:787 ||| IN
the  ||| S:787 E:791 ||| DT
procedures  ||| S:791 E:802 ||| NNS
to  ||| S:802 E:805 ||| TO
image  ||| S:805 E:811 ||| VB
the  ||| S:811 E:815 ||| DT
leptomeningeal  ||| S:815 E:830 ||| JJ
vessels  ||| S:830 E:838 ||| NNS
of  ||| S:838 E:841 ||| IN
the  ||| S:841 E:845 ||| DT
thoracic  ||| S:845 E:854 ||| JJ
spinal  ||| S:854 E:861 ||| JJ
cord  ||| S:861 E:866 ||| NN
during  ||| S:866 E:873 ||| IN
transfer  ||| S:873 E:882 ||| FW
experimental  ||| S:882 E:895 ||| FW
autoimmune  ||| S:895 E:906 ||| FW
encephalomyelitis  ||| S:906 E:924 ||| FW
in  ||| S:924 E:927 ||| FW
LEW  ||| S:927 E:931 ||| FW
rats  ||| S:931 E:936 ||| FW
( ||| S:936 E:937 ||| -LRB-
AT  ||| S:937 E:940 ||| NNP
EAE ||| S:940 E:943 ||| NNP
)  ||| S:943 E:945 ||| -RRB-
and  ||| S:945 E:949 ||| CC
in  ||| S:949 E:952 ||| IN
active  ||| S:952 E:959 ||| JJ
EAE  ||| S:959 E:963 ||| NN
in  ||| S:963 E:966 ||| IN
C57BL ||| S:966 E:971 ||| CD
/ ||| S:971 E:972 ||| CD
6  ||| S:972 E:974 ||| CD
mice  ||| S:974 E:979 ||| NNS
( ||| S:979 E:980 ||| -LRB-
aEAE ||| S:980 E:984 ||| NNP
) ||| S:984 E:985 ||| -RRB-
.  ||| S:985 E:987 ||| .
